Biosystems International Merges with MicroBioChips
September 13, 2010
Paris – Biosystems International (BSI), a biotechnology company specializing in the discovery of novel monoclonal antibody based diagnostics, announces its merger with the company MicroBioChips (MBC) by contribution of assets. Advantages of the merger Following a successful partnership to develop monoclonal antibody microarrays, in which BSI provided the antibodies and MBC produced and commercialized the [...]
September 13, 2010
CINCINNATI - Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company's fiscal 2011 sales and earnings estimates. Based on the Company's business planning and budgeting activities for the fiscal year ending September 30, 2011, management expects net sales to be in the range of $165 to $170 [...]
September 13, 2010
Gentel Biosciences, a leader in proteomics profiling tools, announces the availability of thirteen APiX™ Human Tumor Profiling Kits, robust tissue-lysate (reverse-phase) protein arrays and chromogenic-based detection reagents, suitable for the testing of putative protein biomarkers in over thirteen cancer subtypes. The new kits combine Gentel's APiX™ chromogenic detection technology and Protein Biotechnologies, Inc.'s large collection [...]
Thermo Fisher Scientific Introduces Larger Volume Vials for Cryopreservation
September 13, 2010
New Size Thermo Scientific Nunc Cryobank Vials Incorporate Superior 2D Barcode Tracking MILFORD, Mass. - Thermo Fisher Scientific Inc., the world leader in serving science, today announced the new Thermo Scientific Nunc 2 mL and 5 mL Cryobank Vials, completing the integrated portfolio of automation-friendly screw top vials. The larger volume Nunc™ Cryobank vials incorporate [...]
Seegene Raises USD 16.6 Million in Initial Public Offering on KOSDAQ
September 13, 2010
ROCKVILLE, Maryland and SEOUL, Korea - Seegene today announced its successful initial public offering on the KOSDAQ (Korea Securities Dealers Automated Quotations). The company sold 636,500 shares for USD 26.16 (WON 30,500) each, raising USD 16.6 million and giving Seegene a market capitalization of USD 167 million. The company plans to invest the fresh capital [...]
Thermo Fisher Scientific Introduces New Syncronis Range of HPLC Columns at ISC 2010
September 13, 2010
Consistent, Predictable Separations; Column after Column; Time after Time MILFORD, Mass. - Thermo Fisher Scientific Inc., the world leader in serving science, today announced the new Thermo Scientific Syncronis HPLC column range. This new range unerringly delivers consistent, predictable separations, from run to run and column to column. The company will showcase the Syncronis HPLC [...]
September 13, 2010
BOSTON, Massachusetts – At the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Bruker Daltonics Inc. today announced the introduction of the new MALDI Sepsityper™ Kit for the rapid identification of microorganisms from positive blood culture bottles, using Bruker’s industry-leading MALDI Biotyper solution. The MALDI Biotyper has obtained the IVD-CE Mark, and is currently [...]
September 13, 2010
Basel - Flexible “Intelligent LabPower” system helps labs increase efficiency, lets them reconfigure modules for changing needs Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® 8000 modular analyzer series, a Serum Work Area solution designed for diagnostic laboratories [...]
DNA Repair Knockdown Cell Lines
September 10, 2010
Tools to Study Genomic Instability and Genotoxic Stress Trevigen, Inc. is pleased to announce the availability of nineteen DNA repair gene knockdown cell lines, encompassing the Base Excision Repair pathway. These are target specific LN428 glioblastoma shRNA lentivirus transduced cells that are rigorously qualified and mycoplasma free. The percent knockdown levels range from 75% to [...]
Synpromics: Scotland’s Latest Biotech Company
September 10, 2010
Edinburgh, United Kingdom - Synpromics announces its incorporation as Scotland’s latest biotech company. The new company aims to focus its activities in the area of synthetic mammalian biology and has acquired a number of patent applications that arose out of inventions by its founder and managing director; Dr Michael Leslie Roberts. Dr Roberts read Biochemistry [...]

